0000899243-21-032753.txt : 20210812 0000899243-21-032753.hdr.sgml : 20210812 20210812162048 ACCESSION NUMBER: 0000899243-21-032753 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210810 FILED AS OF DATE: 20210812 DATE AS OF CHANGE: 20210812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stuart Bryan CENTRAL INDEX KEY: 0001619846 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38978 FILM NUMBER: 211167861 MAIL ADDRESS: STREET 1: C/O CIVITAS THERAPEUTICS, INC. STREET 2: 190 EVERETT AVENUE CITY: CHELSEA STATE: MA ZIP: 02150 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-08-10 0 0001680581 Fulcrum Therapeutics, Inc. FULC 0001619846 Stuart Bryan C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 1 0 0 See Remarks Common Stock 2021-08-10 4 M 0 32000 7.84 A 32000 D Common Stock 2021-08-10 4 S 0 32000 17.50 D 0 D Common Stock 2021-08-11 4 M 0 28000 7.84 A 28000 D Common Stock 2021-08-11 4 S 0 28000 23.75 D 0 D Stock Option (right to buy) 7.84 2021-08-10 4 M 0 32000 0.00 D 2028-12-17 Common Stock 32000 271571 D Stock Option (right to buy) 7.84 2021-08-11 4 M 0 28000 0.00 D 2028-12-17 Common Stock 28000 243571 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. This option was granted on December 18, 2018 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of December 18, 2018. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service. President & Chief Executive Officer /s/ Peter Thomson, as attorney-in-fact for Bryan Stuart 2021-08-12